Skip to main content
. 2020 Feb 1;27(1):39–45. doi: 10.3747/co.27.5621

TABLE II.

Treatment and survival by inpatient or outpatient status at the time of brain metastasis diagnosis

Variable Age group p Value
<40 Years ≥ 40 Years
Patients (n) 17 104 0.059a

Outpatient or inpatient statusb
 Outpatient [n (%)] 13 (76) 54 (52)
  Mean survival (months) 24 7 0.001c
 Inpatient [n (%)] 4 (24) 50 (48)
  Mean survival (months) 13 8 0.248c

Local treatment status [n (%)] 17 104 <0.001
 Supportive care 0 (0) 14 (13.5)
 No local treatment; any systemic treatment 2 (12) 12 (11.5)
 Brain surgery ± RT 1 (6) 13 (12.5)
 Brain RT, no brain surgery 14 (82) 65 (62.5)

Systemic treatment status [n (%)] 17 104 <0.001
 CTx, anti-HER2 therapyd, ± hormonal therapy 12 (71) 37 (36)
 Hormonal therapy (without CTx) 2 (12) 16 (15)
 None 3 (18) 51 (49)

Cohort receiving systemic treatment (n) 14 53 0.014
 Mean survival (months) 21 6
 1-Year survival (%) 63 26
 2-Year survival (%) 42 10
a

Relationship between inpatient or outpatient status and age.

b

At the time of brain metastasis diagnosis.

c

Relationship between mean survival in months and age.

d

When appropriate.

RT = radiation therapy; CTx = chemotherapy.